-+ 0.00%
-+ 0.00%
-+ 0.00%

PROTARA THERAPEUTICS COMPLETES ENROLLMENT OF THE PHASE 2B OPEN-LABEL DOSE CONFIRMATION PHASE OF THE THRIVE-3 REGISTRATIONAL TRIAL OF IV CHOLINE CHLORIDE IN PATIENTS ON PARENTERAL SUPPORT

Reuters·10/15/2026 12:02:44